Capital Markets Day: Commercial Execution and Innovation in Obesity Care

23 Commercial execution and innovation Obesity care The commercial strategic aspiration for Obesity care as communicated in 2019 Commercial execution Strengthen Diabetes leadership - aim at global value market share of more than 1/3 Strengthen Obesity leadership and double current sales¹ Secure a sustained growth outlook for Rare diseased 1 Based on reported sales in 2019 Note: The strategic aspirations are not a projection of Novo Nordisk's financial outlook or expected growth. CMD22 CAPITAL MARKETS DAY Novo NordiskⓇ

View entire presentation